# Nordic 8 - A Phase II Trial

> **NCT01867697** · PHASE2 · COMPLETED · sponsor: **Per Pfeiffer** · enrollment: 173 (actual)

## Conditions studied

- Metastatic Colorectal Cancer

## Interventions

- **DRUG:** Cetuximab
- **DRUG:** Irinotecan
- **DRUG:** Oxaliplatin
- **DRUG:** Folinic Acid
- **DRUG:** Calcium Carbonate

## Key facts

- **NCT ID:** NCT01867697
- **Lead sponsor:** Per Pfeiffer
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-05
- **Primary completion:** 2019-03
- **Final completion:** 2019-03
- **Target enrollment:** 173 (ACTUAL)
- **Last updated:** 2020-10-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01867697

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01867697, "Nordic 8 - A Phase II Trial". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01867697. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*